SNST (Aphex BioCleanse Systems) Cash Conversion Cycle: 0.00 (As of . 20)


What is Aphex BioCleanse Systems Cash Conversion Cycle?

Aphex BioCleanse Systems SNST Cash Conversion Cycle is 0.00 as of . 20.

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Aphex BioCleanse Systems's Days Sales Outstanding for the three months ended in . 20 was .
Aphex BioCleanse Systems's Days Inventory for the three months ended in . 20 was .
Aphex BioCleanse Systems's Days Payable for the three months ended in . 20 was .
Therefore, Aphex BioCleanse Systems's Cash Conversion Cycle (CCC) for the three months ended in . 20 was 0.00.

Aphex BioCleanse Systems  (OTCPK:SNST) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.

Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.

Aphex BioCleanse Systems Cash Conversion Cycle Related Terms

Aphex BioCleanse Systems Cash Conversion Cycle Historical Data

* Premium members only.

The historical data trend for Aphex BioCleanse Systems's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aphex BioCleanse Systems Cash Conversion Cycle Chart

Aphex BioCleanse Systems Annual Data
Trend
Cash Conversion Cycle

Aphex BioCleanse Systems Quarterly Data
Cash Conversion Cycle

Aphex BioCleanse Systems Cash Conversion Cycle Competitor Comparison

For the Household & Personal Products subindustry, Aphex BioCleanse Systems's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aphex BioCleanse Systems Cash Conversion Cycle vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Aphex BioCleanse Systems's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Aphex BioCleanse Systems's Cash Conversion Cycle falls into.


Aphex BioCleanse Systems Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Aphex BioCleanse Systems's Cash Conversion Cycle for the fiscal year that ended in . 20 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=+-
=0.00

Aphex BioCleanse Systems's Cash Conversion Cycle for the quarter that ended in . 20 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=+-
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash Conversion Cycle →
What does a Cash Conversion Cycle of 0.00 mean?
Aphex BioCleanse Systems (SNST) has a Cash Conversion Cycle of 0.00 as of . 20. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Aphex BioCleanse Systems and its competitors.
Is Aphex BioCleanse Systems' Cash Conversion Cycle too high?
Aphex BioCleanse Systems' current Cash Conversion Cycle is 0.00.
How does Aphex BioCleanse Systems' Cash Conversion Cycle compare to competitors?
Aphex BioCleanse Systems' Cash Conversion Cycle of 0.00 can be compared against companies in the Consumer Packaged Goods industry. The industry median Cash Conversion Cycle is 75.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Consumer Packaged Goods company?
The median Cash Conversion Cycle among Consumer Packaged Goods companies is 75.44, based on 1,946 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Aphex BioCleanse Systems and its competitors. For the Consumer Packaged Goods industry, the median Cash Conversion Cycle is 75.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aphex BioCleanse Systems's current Cash Conversion Cycle is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aphex BioCleanse Systems stock overvalued right now?
Aphex BioCleanse Systems (SNST) has a current Cash Conversion Cycle of 0.00. The current Cash Conversion Cycle is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Aphex BioCleanse Systems (SNST), the current Cash Conversion Cycle is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aphex BioCleanse Systems Business Description

Address 1820 State Road 13, Unit 11-43, Saint Johns, FL, USA, 32259
Aphex BioCleanse Systems Inc is a United States-based company that provides sanitization solutions. It develops and manufactures non-alcohol, non-toxic, and hydrogen-based disinfecting technology. The company produces proprietary hydrogen-based disinfectant and pesticide products known as Hy-IQ Water.